Cargando…

Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7

Qb bacteriophage virus-like particles (Qb-VLP) are utilized as carriers to enhance immune responses to weakly or non-immunogenic antigens such as peptides and haptens. Qb-VLPs are formed through the self-assembly of multiple Qb capsid protein monomers, a process which traps a large amount of bacteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akache, Bassel, Weeratna, Risini D., Deora, Aparna, Thorn, Jennifer M., Champion, Brian, Merson, James R., Davis, Heather L., McCluskie, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810055/ https://www.ncbi.nlm.nih.gov/pubmed/26805897 http://dx.doi.org/10.3390/vaccines4010003

Ejemplares similares

Immunogenicity of a peptide‐based anti‐IgE conjugate vaccine in non‐human primates
por: Weeratna, Risini D., et al.
Publicado: (2016)

CpG ODN and ISCOMATRIX Adjuvant: A Synergistic Adjuvant Combination Inducing Strong T-Cell IFN-γ Responses
por: McCluskie, Michael J., et al.
Publicado: (2013)

An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma
por: Stark, Felicity C., et al.
Publicado: (2017)

Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
por: Perera, Dilhan J., et al.
Publicado: (2020)

Blood-Based Immune Protein Markers of Disease Progression in Murine Models of Acute and Chronic Inflammatory Bowel Disease
por: Renner, Tyler Milston, et al.
Publicado: (2023)

Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice
por: Akache, Bassel, et al.
Publicado: (2018)

Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
por: Jia, Yimei, et al.
Publicado: (2022)

Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma
por: Stark, Felicity C., et al.
Publicado: (2019)

The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model
por: Jia, Yimei, et al.
Publicado: (2021)

Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity
por: McCluskie, Michael J., et al.
Publicado: (2017)

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
por: Akache, Bassel, et al.
Publicado: (2019)

Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8(+) T Cells that Protect Against Subcutaneous B16-OVA Melanoma
por: Stark, Felicity C., et al.
Publicado: (2016)

Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious
por: Akache, Bassel, et al.
Publicado: (2023)

Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations
por: Agbayani, Gerard, et al.
Publicado: (2020)

Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern
por: Renner, Tyler M., et al.
Publicado: (2023)

Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
por: Hankaniemi, Minna M., et al.
Publicado: (2020)

Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
por: Akache, Bassel, et al.
Publicado: (2021)

Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
por: Stark, Felicity C., et al.
Publicado: (2022)

Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model
por: Akache, Bassel, et al.
Publicado: (2021)

Alum‐adjuvanted allergoids induce functional IgE‐blocking antibodies
por: Reithofer, M., et al.
Publicado: (2018)

QB VII
por: Uris, Leon, 1924-2003
Publicado: (1972)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE(+) B cells
por: Hu, Jiayun, et al.
Publicado: (2018)

Tuning IgE: IgE-Associating Molecules and Their Effects on IgE-Dependent Mast Cell Reactions
por: Ando, Tomoaki, et al.
Publicado: (2021)

Regulation of IgE activity in inhalational tolerance via formation of IgG anti-IgE/IgE immune complexes
por: Bracken, Sonali J., et al.
Publicado: (2018)

Ringbodies in Anæmia
por: Monro, T. K., et al.
Publicado: (1925)

IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance via Fc Receptors
por: Plattner, Kevin, et al.
Publicado: (2022)

TLR2 deficiency promotes IgE and inhibits IgG1 class-switching following ovalbumin sensitization
por: Li, Yuqin, et al.
Publicado: (2021)

Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti‐IgE/IgE immune complexes
por: Bundhoo, A., et al.
Publicado: (2015)

IgE-Related Chronic Diseases and Anti-IgE-Based Treatments
por: Navinés-Ferrer, Arnau, et al.
Publicado: (2016)

Self-reactive IgE and anti-IgE therapy in autoimmune diseases
por: Olewicz-Gawlik, Anna, et al.
Publicado: (2023)

Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences
por: Chikh, Ghania, et al.
Publicado: (2016)

Development of the covalent antibody-DNA conjugates technology for detection of IgE and IgM antibodies by immuno-PCR
por: Maerle, Artem V., et al.
Publicado: (2019)

Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling
por: Leuthard, Deborah S., et al.
Publicado: (2018)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2018)

Peroxisomes Regulate Cellular Free Fatty Acids to Modulate Mast Cell TLR2, TLR4, and IgE-Mediated Activation
por: Meghnem, Dihia, et al.
Publicado: (2022)

Relationships between Levels of Serum IgE, Cell-Bound IgE, and IgE-Receptors on Peripheral Blood Cells in a Pediatric Population
por: Dehlink, Eleonora, et al.
Publicado: (2010)

Profound differences in IgE and IgG recognition of micro‐arrayed allergens in hyper‐IgE syndromes
por: Garib, Victoria, et al.
Publicado: (2021)

IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab
por: Maronese, Carlo Alberto, et al.
Publicado: (2023)

Allergen skin test reactivity and asthma are inversely associated with ratios of IgG4/IgE and total IgE/allergen‐specific IgE in Ugandan communities
por: Nkurunungi, Gyaviira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ljqck5selafljffr9gi4pmh8sk